**DEAR EDITOR**,

Protein arginine methyltransferases (PRMTs) are involved in many cellular processes via the arginine methylation of histone or non-histone proteins. We examined the expression patterns of *prmt4*, *prmt7*, and *prmt9* during embryogenesis in *Xenopus* using whole-mount *in situ* hybridization and quantitative reverse transcription polymerase chain reaction (RT-PCR). *Xenopus prmt4* and *prmt7* were expressed in the neural crest, brain, and spinal cord, and also detected in the eye, branchial arches, and heart at the tailbud stage. Specific *prmt9* signals were not detected in *Xenopus* embryos until the late tailbud stage when weak expression was observed in the branchial arches. Quantitative RT-PCR indicated that the expression of *prmt4* and *prmt7* was up-regulated during the neurula stage, whereas *prmt9* maintained its low expression until the late tailbud stage, consistent with the whole-mount *in situ* hybridization results. Thus, the developmental expression patterns of these three *prmt* genes in *Xenopus* embryos provide a basis for further functional study of such genes.

Post-translational modification plays an essential role in modulating the structure and function of a protein ([@B20-ZoolRes-40-2-102]). Arginine methylation is a common post-translational modification in vertebrates, and is mediated by protein arginine methyltransferases (PRMTs) ([@B3-ZoolRes-40-2-102]; [@B5-ZoolRes-40-2-102]). PRMTs can catalyze the transfer of a methyl group from S-adenosylmethionine (SAM) to the guanidine nitrogen atoms of arginine to form methylarginine ([@B12-ZoolRes-40-2-102]). Based on the number and symmetry of the methyl group in methylarginine, PRMTs can be divided into three categories. PRMT4 (type I PRMT) and PRMT9 (type II PRMT) catalyze the formation of asymmetric and symmetric dimethylarginine, respectively ([@B6-ZoolRes-40-2-102]; [@B22-ZoolRes-40-2-102]), whereas PRMT7 (type III PRMT) catalyzes the formation of monomethylarginine ([@B8-ZoolRes-40-2-102]; [@B7-ZoolRes-40-2-102]).

The PRMT-mediated arginine methylation of histone or non-histone proteins is involved in many cellular processes, including transcriptional regulation, signal transduction, and RNA splicing ([@B3-ZoolRes-40-2-102]; [@B5-ZoolRes-40-2-102]; [@B23-ZoolRes-40-2-102]). PRMT4, also known as coactivator associated arginine methyltransferase 1 (CARM1), can regulate the cell cycle through arginine methylation of the retinoblastoma protein tumor suppressor ([@B15-ZoolRes-40-2-102]). PRMT9 can methylate SAP145, a component of the U2 snRNP involved in the early stages of splicing, with attenuation of PRMT9 also known to cause gross changes in RNA splicing ([@B23-ZoolRes-40-2-102]).

PRMT7 is required for the maintenance of the regeneration capacity of muscle stem cells by regulating the DNMT3b/p21 axis ([@B4-ZoolRes-40-2-102]). Specific knockout of *PRMT7* in muscle stem cells can cause elevated expression of CDK inhibitor p21CIP1 and reduced expression of its repressor, DNMT3b, leading to cell-cycle arrest and premature cellular senescence, which can be rescued by restoration of DNMT3b ([@B4-ZoolRes-40-2-102]). Both *prmt4* and *prmt5* play a combinatorial role during zebrafish myogenesis by controlling fast and slow muscle fiber formation ([@B1-ZoolRes-40-2-102]). Furthermore, *prmt4* is also suggested to regulate the expression of myogenic microRNAs directly ([@B19-ZoolRes-40-2-102]).

Although PRMTs are widely involved in various cellular processes via catalyzing the methylation of target proteins, their roles in embryonic development are not yet well understood. Limited studies have shown that PRMT4 and PRMT7 are involved in myogenesis ([@B1-ZoolRes-40-2-102]; [@B4-ZoolRes-40-2-102]; [@B19-ZoolRes-40-2-102]). *Xenopus* is an excellent model in developmental biology ([@B10-ZoolRes-40-2-102]), and all *prmt* genes (*prmt1*--*9*) have been identified in the *Xenopus tropicalis* genome. In this study, we selected three *prmt* genes, that is, *prmt4*, *prmt7,* and *prmt9*, and studied their spatial and temporal expression patterns during the embryonic development of *Xenopus*. Our study will provide a basis for further investigations on the functions of *prmt* genes in *Xenopus*.

We searched *prmt* genes of *Xenopus tropicalis* and other species in the NCBI database (Supplementary Table S1, available online). Protein sequence alignments were performed using Geneious v4.8.5 ([www.geneious.com/previous-versions/\#geneious-4-dot-8](www.geneious.com/previous-versions/#geneious-4-dot-8)), with a dendrogram tree then constructed using neighbor-joining in the same program.

*Xenopus laevis prmt4* (NM_001094676), *prmt7* (NM_001086541), and *prmt9* (NM_001096961) sequences were obtained by searching the NCBI database. The open reading frames (ORFs) of *prmt4*, *prmt7*, and *prmt9* were amplified using reverse transcription polymerase chain reaction (RT-PCR). The PCR products were subcloned into the pBluescript II KS (+) vector and verified by sequencing. To prepare probes for *in situ* hybridizations, plasmids were linearized by cutting with *Xho*1 and used as templates for the synthesis of digoxigenin-labeled anti-sense probes with T7 RNA polymerase (Roche, Indianapolis, USA).

*Xenopus laevis* embryos were collected, cultured, and fixed as described previously ([@B21-ZoolRes-40-2-102]). Whole-mount *in situ* hybridization was performed according to standard methods ([@B9-ZoolRes-40-2-102]). After *in situ* hybridization, the embryos were embedded and sectioned at a thickness of 50 μm. Detailed information on the vibratome sections is described in our previous study ([@B14-ZoolRes-40-2-102]).

Total RNA was extracted from *Xenopus tropicalis* embryos using TRIzol reagent (Molecular Research Center Inc., USA). The cDNA was synthesized using the ReverTra Ace^®^ qPCR RT Kit (Toyobo, Japan). Quantitative PCR was performed using the SYBR^®^ Green real-time PCR master mix (Toyobo, Japan). The primer sequences used are listed in [Table 1](#ZoolRes-40-2-102-t001){ref-type="table"}. *Ornithine decarboxylase* (*odc*) was used as the internal control.
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Primers for quantitative RT-PCR

  Gene      Sequence (5′--3′)
  --------- -----------------------------
  *prmt1*   Fw: CAAACATGGCTGAAGCGAGC
            Re: ACATCTCCTCATGGATGCCAAAG
  *prmt2*   Fw: ACAGCCTGCATTCACTTGGT
            Re: TAATCAGGCTTGGGTCTGGC
  *prmt3*   Fw: AAGATGTGGATCTGCCCGTG
            Re: CAGGTATCGGGGTACACTGC
  *prmt4*   Fw: GGAGATCCAGAGACACGCTG
            Re: TGCATTTGAACACGCAGACG
  *prmt6*   Fw: GGCCAGTAGTATGTCCCAGC
            Re: GCGTACCCCATCCATTCACT
  *prmt7*   Fw: TGCGTGTGGTACAGCCTAAC
            Re: AATGACATGCAGGACGCTCT
  *prmt9*   Fw: TTGATGCAGGCTTGTTTGGC
            Re: TCTGGGCACTCTACTGCCAT
  *odc*     Fw: GGGCAAAAGAGCTTAATGTGG
            Re: TGCCAACATGGAAACTTACA

We performed whole-mount *in situ* hybridization to examine the spatial expression of *prmt* genes in *Xenopus* embryos. No evident signals were detected before gastrulation. In the early gastrula stage, the *prmt4* signal was mainly expressed in the dorsal ectoderm, which gives rise to the neural ectoderm ([Figure 1](#ZoolRes-40-2-102-f001){ref-type="fig"}A). At the early neurula stage, the *prmt4* signal was enriched in the anterior region of the neural plate as well as the posterior region around the blastopore ([Figure 1](#ZoolRes-40-2-102-f001){ref-type="fig"}B). After this, *prmt4* was strongly expressed in the neural plate and neural crest ([Figure 1](#ZoolRes-40-2-102-f001){ref-type="fig"}C, D). This expression pattern persisted when neural crest migration began in the later neurula stage ([Figure 1](#ZoolRes-40-2-102-f001){ref-type="fig"}E, F). During the tailbud stage, *prmt4* was detected throughout the central nervous system, including the brain and spinal cord ([Figure 1](#ZoolRes-40-2-102-f001){ref-type="fig"}G, H). Strong expression was also observed in the branchial arches and eye vesicles ([Figure 1](#ZoolRes-40-2-102-f001){ref-type="fig"}G, H). In stage 35, *prmt4* expression was enriched in the head region, including the forebrain, midbrain, hindbrain, eye, and branchial arches ([Figure 1](#ZoolRes-40-2-102-f001){ref-type="fig"}I, J). In stage 40, *prmt4* was expressed in the olfactory placode, jaw, and heart, and weak expression in the paraxial mesoderm was also observed ([Figure 1](#ZoolRes-40-2-102-f001){ref-type="fig"}K--R). Weak signals were also detected in the eye, brain, dorsal region of the endoderm, and spinal cord ([Figure 1](#ZoolRes-40-2-102-f001){ref-type="fig"}N--R).

![Spatial expression of *prmt4* in *Xenopus* embryos](ZoolRes-40-2-102-g001){#ZoolRes-40-2-102-f001}

No apparent expression of *prmt7* was detected in the embryos at the early gastrula stage (data not shown). In the early neurula stage, *prmt7* was weakly expressed in the neural plate ([Figure 2](#ZoolRes-40-2-102-f002){ref-type="fig"}A). The expression of *prmt7* intensified and expanded to the migrating neural crest, anterior neural tube, and somites ([Figure 2](#ZoolRes-40-2-102-f002){ref-type="fig"}B, C), and then showed strong expression in the branchial arches during the tailbud stage ([Figure 2](#ZoolRes-40-2-102-f002){ref-type="fig"}D, E). At stage 25, *prmt7* expression was also detected in the intermediate mesoderm ([Figure 2](#ZoolRes-40-2-102-f002){ref-type="fig"}D). At stage 29, *prmt7* signals were detected in the brain, eye, and somites ([Figure 2](#ZoolRes-40-2-102-f002){ref-type="fig"}E--H). Weak expression was also observed in the pronephric tubule ([Figure 2](#ZoolRes-40-2-102-f002){ref-type="fig"}I). At stage 40, *prmt7* was strongly expressed in the branchial arches, with weak signals in the heart, eye, brain, and olfactory placode ([Figure 2](#ZoolRes-40-2-102-f002){ref-type="fig"}J--L).

![Expression of *prmt7* in *Xenopus* embryos](ZoolRes-40-2-102-g002){#ZoolRes-40-2-102-f002}

Whole-mount *in situ* hybridization could not detect specific signals of *prmt9* in *Xenopus* embryos at almost every stage, though a weak signal was observed in the branchial arches at the late tailbud stage (data not shown).

We studied the temporal expression patterns of *Xenopus prmt* genes using quantitative RT-PCR. Different from pseudotetraploid *Xenopus laevis*, the diploid *Xenopus tropicalis* species has two sets of chromosomes. Thus, we collected *Xenopus tropicalis* embryos at different stages and measured the mRNA expression levels of *prmt1--4*, *prmt6*, *prmt7*, and *prmt9* ([Figure 3](#ZoolRes-40-2-102-f003){ref-type="fig"}). Maternal expression of *prmt6* and *prmt7* was detected, which decreased during the cleavage stage ([Figure 3](#ZoolRes-40-2-102-f003){ref-type="fig"}E, F). Apart from *prmt7,* the expression levels of the detected *prmt* genes were low during the gastrula stage ([Figure 3](#ZoolRes-40-2-102-f003){ref-type="fig"}F). The expression of *prmt4*, *prmt6*, and *prmt7* were gradually up-regulated from the neurula stage ([Figure 3](#ZoolRes-40-2-102-f003){ref-type="fig"}D--F). However, the expression levels of *prmt2*, *prmt3*, and *prmt9* increased from the tailbud stage ([Figure 3](#ZoolRes-40-2-102-f003){ref-type="fig"}B, C, G). During the late tailbud stage, most of the *prmt* genes maintained their high expression levels, except for *prmt2* and *prmt9*, whose expression continued to increase ([Figure 3](#ZoolRes-40-2-102-f003){ref-type="fig"}B, G). The expression of *prmt9* remained low before the late tailbud stage ([Figure 3](#ZoolRes-40-2-102-f003){ref-type="fig"}G). In contrast, *prmt1* expression reached a high level at the early neurula stage ([Figure 3](#ZoolRes-40-2-102-f003){ref-type="fig"}A). The up-regulation in the expression of *prmt4* and *prmt7* during neurulation ([Figure 3](#ZoolRes-40-2-102-f003){ref-type="fig"}D, F) accords with their enhanced staining of embryos, as revealed by whole-mount *in situ* hybridization ([Figure 1](#ZoolRes-40-2-102-f001){ref-type="fig"}B--F; [Figure 2](#ZoolRes-40-2-102-f002){ref-type="fig"}A*--*C). The low expression level of *prmt9* before the late tailbud stage ([Figure 3](#ZoolRes-40-2-102-f003){ref-type="fig"}G) is consistent with the slight staining of embryos after *in situ* hybridization.

Searching the NCBI database we found that all *prmt* genes, including *prmt1--9*, have been identified in *Xenopus tropicalis*. A phylogenetic tree based on their protein sequence alignments was generated ([Figure 4](#ZoolRes-40-2-102-f004){ref-type="fig"}A). Results showed that type I PRMTs (prmt1, prmt2, prmt3, prmt4, prmt6, and prmt8) exhibited fewer genetic changes, whereas prmt5 and prmt7 demonstrated more significant genetic variation ([Figure 4](#ZoolRes-40-2-102-f004){ref-type="fig"}A). We conducted phylogenetic analysis of the *Xenopus* prmt4, prmt7, and prmt9 proteins to illustrate their evolutionary distances to humans, mice, chickens, frogs, and zebrafish ([Figure 4](#ZoolRes-40-2-102-f004){ref-type="fig"}B).

![Quantitative RT-PCR analysis of *prmt* gene expression in *Xenopus tropicalis* embryos](ZoolRes-40-2-102-g003){#ZoolRes-40-2-102-f003}

![Phylogenetic analysis of prmt proteins](ZoolRes-40-2-102-g004){#ZoolRes-40-2-102-f004}

We examined the expression patterns of three *prmt* genes during embryonic development. Our results indicated that *prmt4* and *prmt7* showed similar expression patterns. Both were expressed in the neural plate during neurulation and were then detected in the brain and spinal cord ([Figure 1](#ZoolRes-40-2-102-f001){ref-type="fig"} and [Figure 2](#ZoolRes-40-2-102-f002){ref-type="fig"}). These data suggest that *prmt4* and *prmt7* function in neural development, similar to that found in other PRMT members ([@B2-ZoolRes-40-2-102]; [@B11-ZoolRes-40-2-102]; [@B13-ZoolRes-40-2-102]; [@B16-ZoolRes-40-2-102]; [@B17-ZoolRes-40-2-102]; [@B18-ZoolRes-40-2-102]). Furthermore, *prmt4* and *prmt7* were both expressed in the neural crest, which has not been reported previously. Apart from the brain, *prmt4* and *prmt7* were also expressed in other regions of the head, including the eye and branchial arches. At the late tailbud stage, both were detected in the olfactory placode, pharyngeal arches, and heart regions ([Figure 1](#ZoolRes-40-2-102-f001){ref-type="fig"}K, N--R; [Figure 2](#ZoolRes-40-2-102-f002){ref-type="fig"}F, J--L). In zebrafish, the expression of *prmt8* has also been detected in the heart at the later stages ([@B18-ZoolRes-40-2-102]). Here, weak *prmt4* signals were detected in the paraxial mesoderm ([Figure 1](#ZoolRes-40-2-102-f001){ref-type="fig"}M), whereas *prmt7* was evidently expressed in the somites ([Figure 2](#ZoolRes-40-2-102-f002){ref-type="fig"}C, G). These results are in agreement with their potential roles in myogenesis, which have been studied to some extent in zebrafish ([@B1-ZoolRes-40-2-102]). In addition, *prmt4* and *prmt7* also shared similar temporal expression patterns at the neurula and tailbud stages when their expression levels were gradually up-regulated ([Figure 3](#ZoolRes-40-2-102-f003){ref-type="fig"}D, F). The high similarity in expression patterns between *prmt4* and *prmt7* implies that different members of the PRMT family may have redundant roles in regulating early embryonic development. Compared with other examined *prmt* genes, *prmt9* exhibited a distinct temporal expression pattern. Its expression level was very low before the early tailbud stage but was dramatically elevated from the late tailbud stage ([Figure 3](#ZoolRes-40-2-102-f003){ref-type="fig"}G). This is in line with the *in situ* hybridization results, in which specific *prmt9* signals were not detected until the late tailbud stage. Although prmt9 is a non-histone methyltransferase involved in regulating RNA splicing ([@B23-ZoolRes-40-2-102]), whether the special expression pattern of *prmt9* is related to its role in RNA splicing remains to be illustrated. This study will facilitate further functional study of *prmt* genes during embryonic development.
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